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1038-152 Lack of Interferon-g Modulates Systolic but Not 
Diastolic Function During the Acute Phase of Murine 
Autoimmune Myocarditis 
Marina Afanasveva, Dimitrios Georgakopelous, DeLisa Fairweather, Yan Wang, Ziya 
Kaya, Patdzio Caturegli, David A. Kass, Noel R. Rosa, Johns Hopkins Medical 
Institutions, Baltimore, Maryland. 
Background: The mechanisms of the development of heart failure in myocarditis remain 
unclear. To study these mechanisms, we established a mudne model of experimental 
autoimmune myocarditis (EAM) and showed that interferon-g (IFN-g) is a key immune 
regulator. In this study, we examined the effects of the absence of IFN-g on the cardiac 
function during the peak myocardial inflammation. 
Methods: On days 0 and 7, wild type (WT) and IFN-g knock out (KO) mice were immu- 
nized with murine cardiac myosin. On day 21, we performed studies of pressure-volume 
relations. Histologic sections of the heart were examined by two independent investiga- 
tors in a blind fashion. 
Results: Higher histologic scores in both the WT and KO mice correlated with diastolic 
dysfunction (increased diastolic stiffness b, normalized to either heart weight or end-dias- 
tolic volume (EDV), and the time constant of left ventricular relaxation tau). However, 
several load-independent indices of systolic function were reduced with higher histologic 
scores in the WT (power maximum/EDV, p=0.04, and maximal rate of pressure develop- 
ment/EDV, p=0.03, Spearman rank correlation) but not in the KO mice. In fact, the KO 
mice had significantly higher power maximum/EDV and maximal rate of pressure devel- 
opment/EDV (p=0.01 and p=0.006, respectively, two-tail Student t test) compared to the 
WT. In addition, the KO mice had significantly lower EDV and end-systolic volumes and 
significantly higher peak filling rate/EDV compared to the WT. Reduced intracardiac vol- 
umes in the KO mice were associated with the presence of paricardial adhesions to the 
surrounding tissues that were not observed in the WT mice. 
Conclusions: Depressed diastolic function correlates with the degree of myocardial 
inflammation regardless of the genotype. Lack of IFN-g results in relative preservation of 
systolic function during the peak of myocardial inflammation in EAM. Additionally, the KO 
mice demonstrate a more restrictive phenotype compared to the WT. 
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1039-138 High Specificity and Negative Predictive Value of 
Exercise Testing for Long-Term Mortality in 
Asymptomstic Men 
Samia Mora. Yadong Cui, Maura K. Whiteman, Jodi A. Flaws, Roger S. Blumenthal, 
Johns Hopkins Medical Institutions, Baltimore, Maryland, University of Maryland School 
of Medicine, Baltimore, Maryland. 
Background: Despite the widespread use of exercise tolerance tests (ETTs) in diagnos- 
ing coronary heart disease (CHD), little is known about its role in screening asymptom- 
atic men. We investigated the role of ETTs in predicting long-term mortality outcomes in 
men without known CHD. 
Methods: 3,775 men betwee ages 30-80 years old without prior myocardial infarction or 
symptoms of angina or claudication who were enrolled in the Lipid Research Clinics 
Prevalence Study underwent baseline Bruce protocol ETTs from 1972-1976 and were 
followed until 1995. Positive ETTs had _>1 mm ST deviation or ventdcular tachycardia, or 
had no ST changes but lasted < 6 minutes. Negative ETTs had no ST changes, lasted _>6 
minutes, and met 90% maximal predicted heart rate. 
Results: 10% (375/3775) of participants tested positive. After an average follow-up of 20 
years, the specificity and negative predictive value (NPV) of the baseline ETT for predict- 
ing long-term CHD and cardiovascular (CVD) death were very high, in contrast o its low 
sensitivity. The age-adjusted relative risks for CHD and CVD mortality associated with a 
positive ETT were 2.0 and 2.1, respectively (p=0.001, 0.0001), and for all-cause mortality 
1.6 (p=0.0001). 
Conclusion: The higher cardiovascular mortality associated with a positive ETT sug- 
gests that it may identify asymptomatic men without known CHD who could benefit from 
comprehensive risk factor modification. In contrast, a negative E'I-F is associated with a 
very favorable long-term prognosis. 
ETT CHD Death CVD Death All-Cause Death 
Sensitivity % 30 34 29 
Specificity % 90 91 93 
NPV % 97 95 87 
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1039-137 Pretest and Exercise Test Scores Stratify Patients With 
Suspected Coronary Disease for Mortality as Well as for 
the Probability of Coronary Artery Disease Presence 
Anthony P. Morise. Farrukh Jails/, West Virginia University School of Medicine, 
Morgantown, West Virginia. 
Background: Pretest and exercise test scores have been validated as good predictors 
of the probability of coronary artery disease presence. Methods: To determine how well 
these previously validated pretest and exercise test scores predict all-cause mortality, we 
utilized 3354 consecutive patients with symptoms of suspected coronary disease and 
interpretable resting ECGs who underwent exercise testing between 1995 and 2001. 
Patients on digitalis were excluded. Pretest score incorporated age, sex, symptoms, and 
6 other risk factors. Exercise test score incorporated age, sex, symptoms, 2-3 risk fac- 
tors, and 3 exercise test variables. Both scores categorized patients into low, intermedi- 
ate, and high risk of coronary disease presence subgroups. Analysis utilized contingency 
tables and Kaplan-Meier method. Results: There were 42 deaths (1.3%) with a mean 
follow-up was 2.7+1.6 years. When evaluated separately, either score was a good pre- 
dictor of risk (p<0.0001). The table below displays the stratification of mortality using both 
scores together. * p=0.025 for intermediate pretest probability group (middle column). 
Conclusion: Both pretest and exercise test scores, that were developed to stratify 
patients by their risk of angiographic coronary disease presence, also stratify patients 
well according to mortality. 
Pretest Score (Columns) vs Exercise Test Score (Rows) 
Low Intermediate * High 
High 0 2/50 (4.0%) 5/94 (5.3%) 
Intermediate 0/66 (0%) 17/579 (2.9%) 3/195 ( 1.5%) 
Low 5/1460 (0.3%) 10/902 (1.1%) 0/8 (0%) 
1039-139 External Validation of a Sophisticated Exercise Testing 
Laboratory Mortality Prediction Rule 
Anthony P. Morise, Eugene H. Blackstone, Michael S. Lauer, Cleveland Clinic 
Foundation, Cleveland, Ohio, West Virginia University, Morgantown, West Virginia. 
Background: The prognostic value of exercise testing, especially when considered 
alongside clinical variables, is increasingly appreciated. In this study we sought to exter- 
nally validate a sophisticated mortality prediction rule for patients undergoing exercise 
testing. 
Methods: A prediction rule was derived by proportional hazards modeling on a training 
set of 30,006 Cleveland Clinic patients (age 56+11, 70% male) who had no history of 
head failure, valve disease, or atrial fibrillation. 29 variables covering demographics, risk 
factors, cardiac history, medications, exercise hemodynamics, and ECG findings at rest 
and during exercise were considered. The resulting model was tested on 4562 patients 
(age 52_+12, 55% male) who underwent exercise testing at West Virginia University. 
Results: In the training dataset there were 2027 deaths during 5 years of follow-up. A 
risk score was derived based on 21 variables that were independently associated with 
death and cut-points according to quint/lee of risk score were determined. In the valida- 
tion dataset here were 121 deaths over 3 years of follow-up. The Figure shows predicted 
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There was very good agreement of predicted and actual death rates across the entire 
spectrum of risk, 
Conclusion: We have externally validated a mortality prediction rule for patients under- 
going exercise testing. This rule can be programmed into personal computers for routine 
clinical use. 
